Market Cap 78.67M P/E - EPS this Y 26.70% Ern Qtrly Grth -
Income -15.81M Forward P/E -3.09 EPS next Y -3.00% 50D Avg Chg -16.00%
Sales 10M PEG -0.13 EPS past 5Y - 200D Avg Chg -14.00%
Dividend N/A Price/Book 2.89 EPS next 5Y 39.60% 52W High Chg -55.00%
Recommedations 2.70 Quick Ratio 3.21 Shares Outstanding 74.92M 52W Low Chg 150.00%
Insider Own 4.95% ROA -24.08% Shares Float 58.70M Beta -
Inst Own 49.66% ROE -75.24% Shares Shorted/Prior 6.25M/6.67M Price 1.05
Gross Margin -55.48% Profit Margin -158.06% Avg. Volume 2,939,672 Target Price 1.17
Oper. Margin -144.18% Earnings Aug 11 Volume 2,270,280 Change 16.01%
Regulus Therapeutics Inc. News
05/14/21 Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit
05/13/21 Regulus (RGLS) Reports Q1 Loss, Misses Revenue Estimates
05/13/21 Regulus Therapeutics Reports First Quarter 2021 Financial Results and Recent Updates
05/13/21 Regulus Therapeutics, Inc. to Host Earnings Call
05/06/21 Regulus (RGLS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
05/03/21 Regulus Therapeutics' RGLS4326 Reports Mixed Bag On Polycystic Kidney Disease-Associated Biomarker Study
05/03/21 Regulus Therapeutics Announces Top-Line Data from the First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
04/15/21 Regulus Therapeutics Announces Completion of Dosing in the First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
04/07/21 Regulus Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
03/10/21 Investors Who Bought Regulus Therapeutics (NASDAQ:RGLS) Shares A Year Ago Are Now Up 101%
03/09/21 Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates
03/05/21 Regulus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
03/04/21 Will Regulus (RGLS) Report Negative Q4 Earnings? What You Should Know
02/10/21 Regulus Therapeutics Announces Completion of Enrollment in First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
01/27/21 Regulus Announces Addition to Board of Directors
01/05/21 Regulus Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference
12/09/20 Are Options Traders Betting on a Big Move in Regulus Therapeutics (RGLS) Stock?
12/08/20 Regulus Therapeutics Announces Closing of $19.4 Million Private Placement of Equity
12/02/20 Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States and Europe. Its two lead product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS4326, an anti-miR targeting miR-17, which is in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products, which include RGLS5579 to inhibit miR-10b, and Hepatitis B virus program and Non-Alcoholic Steatohepatitis program. Regulus Therapeutics Inc. was founded in 2007 and is headquartered in San Diego, California.

RGLS Chatroom

User Image wildDarling Posted - 3 hours ago

$RGLS Nice move today.

User Image ProfessorDman1 Posted - 3 hours ago

$ONTX $CMMB $OBLN $POAI $RGLS bios are hot and gaining momentum ๐Ÿ“š

User Image ToroDelFuego Posted - 3 hours ago

$RGLS I donโ€™t see anything getting in the way of this getting back to $1.40 soon. Iโ€™ll be thrilled if it happens by the end of this week.๐Ÿ”ฅ๐Ÿ‘€

User Image BCochanator Posted - 3 hours ago

$RGLS

User Image dln101 Posted - 3 hours ago

$RGLS nice! lets get back over $1.30s ๐Ÿ’ช๐Ÿ“ˆ

User Image pocketmoney Posted - 4 hours ago

$RGLS someone tag Atlas trading ๐Ÿ˜ฌ. May go back to $2 ๐Ÿคทโ€โ™‚๏ธ

User Image WallStreetOdds_ Posted - 5 hours ago

$RGLS Out of the 93 other times RGLS was up 14.9% during a trading day, 67% of the time it traded lower by the same day's market close. wallstreetodds.com

User Image Angerfurnace Posted - 6 hours ago

$RGLS so who turned the doom switch off

User Image bearorbullz Posted - 6 hours ago

$RGLS judgement day this Friday

User Image jheerdink Posted - 7 hours ago

$INMB $RGLS $ATOS $FATE $NBSE biotechs trending nicely on Tuesday!

User Image Binda Posted - 7 hours ago

$RGLS More to go

User Image algoslingah Posted - 7 hours ago

$RGLS is up 10.8% from market open on 1,126,432 volume #tenpercentscan

User Image ToroDelFuego Posted - 8 hours ago

$RGLS Very nice. We should continue to run up to Fridayโ€™s event.๐Ÿ”ฅ๐Ÿ‘€

User Image Pafist Posted - 8 hours ago

$RGLS Come on Jay, earn that raise!

User Image Steve_382 Posted - 8 hours ago

$RGLS moving back to $1.05 to $1.10 over the next week or so. Just my guess.

User Image TheBritishBullrun Posted - 14 hours ago

$RGLS Jay Hagan presenting at the Oppenheimer Rare & Orphan Disease Summit this Friday at 11.35am ET. Letโ€™s hope for some positive news

User Image kaya111111 Posted - 21 hours ago

$RGLS Maybe you should do something to get the share price up and you wouldnโ€™t have to sell so many to cover your taxes ๐Ÿค”

User Image cctranscripts Posted - 23 hours ago

Statement of changes in beneficial ownership of securities https://www.conferencecalltranscripts.com/summary/?id=9422240 $RGLS

User Image insiderbuyingselling Posted - 23 hours ago

$RGLS new insider selling: 4186 shares. http://insiderbuyingselling.com/?t=RGLS

User Image Quantisnow Posted - 23 hours ago

$RGLS ๐Ÿ“œ SEC Form 4 filed by Regulus Therapeutics Inc. https://quantisnow.com/insight/753046?s=s #majorpharmaceuticals #healthcare

User Image cctranscripts Posted - 23 hours ago

Regulus Therapeutics Inc.'s Sr. VP & General Counsel just disposed of 860 shares https://www.conferencecalltranscripts.com/summary/?id=9422244 $RGLS

User Image Newsfilter Posted - 23 hours ago

$RGLS $3,725.54 of shares sold by Hagan Joseph P (President and CEO), reported in a new form 4 filed with the SEC https://newsfilter.io/a/ccdd1db90d04847913be8cf596060710

User Image fla Posted - 23 hours ago

$RGLS [15s. delayed] filed SEC form 4: President and CEO Hagan Joseph P: Disposed 4,186 of Common Stock at price $0.89 on 2021-05-17, dec https://s.flashalert.me/KORkP

User Image lucasoeth Posted - 23 hours ago

$RGLS - FORM 4 Hagan Joseph P sold 4,186 shares for a total cost of $3,726 https://www.sec.gov/Archives/edgar/data/1465278/000120919121033297/xslF345X03/doc4.xml

User Image Quantisnow Posted - 23 hours ago

$RGLS ๐Ÿ“œ SEC Form 4: Aker Christopher Ray sold $765 worth of Common Stock (860 units at $0.89), decreasing direct ownership by 2% to 41,754 units (for tax liability) https://quantisnow.com/insight/753044?s=s #majorpharmaceuticals #healthcare

User Image fla Posted - 23 hours ago

$RGLS [15s. delayed] filed SEC form 4: Sr. VP & General Counsel Aker Christopher Ray: Disposed 860 of Common Stock at price $0.89 on 2021 https://s.flashalert.me/SMFLwe

User Image lucasoeth Posted - 23 hours ago

$RGLS - FORM 4 Aker Christopher Ray sold 860 shares for a total cost of $765 https://www.sec.gov/Archives/edgar/data/1505512/000120919121033296/xslF345X03/doc4.xml

User Image CZARBETS Posted - 1 day ago

$RGLS institutional ownership down 0.9% from 48.5% to 47.6%

User Image ChiefJohn117 Posted - 1 day ago

$RGLS would be nice to see some insider buying in the near future.

User Image bearorbullz Posted - 1 day ago

$RGLS I have a feeling this is gonna rocket this week

Analyst Ratings
HC Wainwright & Co. Buy May 14, 21
HC Wainwright & Co. Buy Nov 25, 20
H.C. Wainwright Buy Nov 25, 20
Wells Fargo Market Perform Nov 25, 20
Wedbush Neutral Nov 25, 20
B. Riley FBR Neutral Nov 25, 20
Wells Fargo Market Perform Nov 25, 20
B. Riley FBR Neutral Nov 25, 20
BMO Capital Market Perform Nov 25, 20